Literature DB >> 8539316

Action of intravenously administered talipexole on the rat striatal neurons receiving excitatory input from nigral dopamine neurons.

H Matsubayashi1, T Amano, Y Hongjing, Y Kohno, M Sasa.   

Abstract

Electrophysiological studies using rats anesthetized with chloral hydrate were performed to elucidate whether or not intravenously injected talipexole acted as a D2 receptor agonist on the striatal neurons in comparison with the action of bromocriptine. The activities of the striatal neurons were extracellularly recorded using a glass microelectrode attached along a seven-barreled micropipette, each barrel of which was filled with talipexole, bromocriptine, SCH23390 (D1 antagonist), domperidone (D2 antagonist), glutamate or 2 M NaCl. These drugs were iontophoretically applied to the immediate vicinity of the target neuron being recorded. The effects of talipexole and bromocriptine were examined on the neurons, whose spikes (induced by the stimulation of the substantia nigra pars compacta) were inhibited by the iontophoretic application of domperidone. Iontophoretic application of talipexole or bromocriptine increased spontaneous firing of these neurons and this increase in firing was also inhibited by iontophoretically applied domperidone. In the same neurons, intravenously administered talipexole (0.01, 0.02 and 0.04 mg/kg) dose-dependently increased firing, and this increase was inhibited by microiontophoretically applied domperidone, but not by SCH23390. On the other hand, the intravenous injection of bromocriptine (0.1, 0.2 and 0.4 mg/kg) also increased the firing rate. However, the increase was not dose-dependent and fluctuated; the firing transiently decreased during the increase in firing with intravenously administered bromocriptine. However, the bromocriptine-induced increase in firing was also suppressed by domperidone, and decrease in firing was inhibited by SCH23390. These findings suggest that talipexole acts as a D2 agonist on the striatal neurons receiving input from substantia nigra pars compacta and increases firing when intravenously applied.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8539316     DOI: 10.1007/bf02245807

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  B-HT 920 stimulates postsynaptic D2 dopamine receptors in the normal rat: electrophysiological and behavioral evidence.

Authors:  P A Johansen; D Clarkl; F J White
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

2.  Excitatory and inhibitory effects of dopamine on neuronal activity of the caudate nucleus neurons in vitro.

Authors:  A Akaike; Y Ohno; M Sasa; S Takaori
Journal:  Brain Res       Date:  1987-08-25       Impact factor: 3.252

3.  Excitation by talipexole, a dopamine D2 agonist, of caudate nucleus neurons activated by nigral stimulation.

Authors:  N Todo; T Momiyama; T Amano; Y Kohno; M Sasa
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

4.  Passive electrical membrane properties of rat neostriatal neurons in an in vitro slice preparation.

Authors:  T Kita; H Kita; S T Kitai
Journal:  Brain Res       Date:  1984-05-21       Impact factor: 3.252

5.  Inhibition from locus coeruleus of caudate neurons activated by nigral stimulation.

Authors:  S Fujimoto; M Sasa; S Takaori
Journal:  Brain Res Bull       Date:  1981-03       Impact factor: 4.077

6.  Growth of cultured human cerebral meningiomas is inhibited by dopaminergic agents. Presence of high affinity dopamine-D1 receptors.

Authors:  U M Schrell; R Fahlbusch; E F Adams; P Nomikos; M Reif
Journal:  J Clin Endocrinol Metab       Date:  1990-12       Impact factor: 5.958

7.  The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment.

Authors:  D Hinzen; O Hornykiewicz; W Kobinger; L Pichler; C Pifl; G Schingnitz
Journal:  Eur J Pharmacol       Date:  1986-11-12       Impact factor: 4.432

8.  Binding of (+)PHNO and other D2-dopamine agonists to D1-dopamine receptors labelled by [3H]SCH 23390.

Authors:  D J Pettibone; J A Totaro; B V Clineschmidt
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

9.  Possible involvement of differing classes of dopamine D-2 receptors in yawning and stereotypy in rats.

Authors:  K Yamada; M Nagashima; H Kimura; S Matsumoto; T Furukawa
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

10.  Potentiation of yawning responses to the dopamine receptor agonists B-HT 920 and SND 919 by pindolol in the rat.

Authors:  K Yamada; S Matsumoto; M Nagashima; K Shirakawa; T Furukawa
Journal:  J Neural Transm Gen Sect       Date:  1990
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.